Sign in
4

Changes in Ownership

abrdn Life Sciences Investors Filed Acc 0001104659-14-049420

Director acquired 1,459 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BONNEY MICHAEL W Director 2014-06-24 Option exercise +1,459 $19.75 $28,815 2,388 D
Derivatives
BONNEY MICHAEL W Director 2014-06-24 Option exercise · Subscription Rights −2,077 0 D
Loading xslF345X03/a4.xml…